BeiGene Net Change in Property, Plant, and Equipment 2014-2024 | ONC
BeiGene annual/quarterly net change in property, plant, and equipment history and growth rate from 2014 to 2024. Net change in property, plant, and equipment can be defined as the overall change in capital expenditures and sales of plant, property and equipment. This field is used if a company does not report separately sales and purchases of plant, property and equipment or is calculated as the sum of purchases and sales of PP&E
- BeiGene net change in property, plant, and equipment for the quarter ending September 30, 2024 was $-0.400B, a 1.17% decline year-over-year.
- BeiGene net change in property, plant, and equipment for the twelve months ending September 30, 2024 was $-1.385B, a 25.58% increase year-over-year.
- BeiGene annual net change in property, plant, and equipment for 2023 was $-0.562B, a 72.66% increase from 2022.
- BeiGene annual net change in property, plant, and equipment for 2022 was $-0.325B, a 23.77% increase from 2021.
- BeiGene annual net change in property, plant, and equipment for 2021 was $-0.263B, a 123.77% increase from 2020.
BeiGene Annual Net Change in Property, Plant, and Equipment
(Millions of US $) |
| 2023 |
$-562 |
| 2022 |
$-325 |
| 2021 |
$-263 |
| 2020 |
$-118 |
| 2019 |
$-90 |
| 2018 |
$-109 |
| 2017 |
$-46 |
| 2016 |
$-23 |
| 2015 |
$-5 |
| 2014 |
$-1 |
| 2013 |
$-0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$17.962B |
$2.459B |
|
BeiGene, Ltd. is a biotechnology company which focused on immuno-oncological therapeutics. The company's clinical-stage drug candidates include BGB-3111, BGB-283, BGB-290, and BGB-A317. BeiGene, Ltd. is based in Camana Bay, Cayman Islands.
|
